2822-50-6 Usage
General Description
3-Nitro-4-(trifluoromethoxy)aniline is a chemical compound with the molecular formula C7H5F3N2O3. It is a substituted aniline derivative, featuring a nitro group and a trifluoromethoxy (CF3O) group attached to the aromatic ring. 3-NITRO-4-(TRIFLUOROMETHOXY)ANILINE is often used as a building block in the synthesis of pharmaceuticals and agrochemicals, as well as in the manufacturing of dyes and pigments. Its unique chemical properties and reactivity make it valuable for a wide range of applications in the chemical industry. However, it is important to handle and use this compound with caution, as it may be hazardous to health and the environment if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 2822-50-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,2 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2822-50:
(6*2)+(5*8)+(4*2)+(3*2)+(2*5)+(1*0)=76
76 % 10 = 6
So 2822-50-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H5F3N2O3/c8-7(9,10)15-6-2-1-4(11)3-5(6)12(13)14/h1-3H,11H2
2822-50-6Relevant articles and documents
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
-
Example 1a, (2010/11/08)
The invention relates to novel products of formula (I): in which p = 0, 1 and 2; A = aryl, heteroaryl, carbocycle or heterocycle; X = single bond, -N(R6)-, -O-, -C(O)-, -S(O)n-, -N(R6)-C(O)-, -N(R6)-C(O)-N(R6')-, -N(R6)-C(S)-N(R6')-, -N(R6)-C(O)O-, -N(R6)
Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
-
Page 100, (2010/02/09)
The present invention relates to a cyclic urea compound of formula I: as defined herein. The invention is also directed to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use, as an inhibitor on a protein kinase. Thus, it is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.
